Sun, Y.; Li, Z.; Jian, H.; Xia, L.; Lu, S.
Impact of KRAS Mutation Subtypes and Co-Occurring Mutations on Response and Outcome in Advanced NSCLC Patients following First-Line Treatment. J. Clin. Med. 2022, 11, 4003.
https://doi.org/10.3390/jcm11144003
AMA Style
Sun Y, Li Z, Jian H, Xia L, Lu S.
Impact of KRAS Mutation Subtypes and Co-Occurring Mutations on Response and Outcome in Advanced NSCLC Patients following First-Line Treatment. Journal of Clinical Medicine. 2022; 11(14):4003.
https://doi.org/10.3390/jcm11144003
Chicago/Turabian Style
Sun, Yingjia, Ziming Li, Hong Jian, Liliang Xia, and Shun Lu.
2022. "Impact of KRAS Mutation Subtypes and Co-Occurring Mutations on Response and Outcome in Advanced NSCLC Patients following First-Line Treatment" Journal of Clinical Medicine 11, no. 14: 4003.
https://doi.org/10.3390/jcm11144003
APA Style
Sun, Y., Li, Z., Jian, H., Xia, L., & Lu, S.
(2022). Impact of KRAS Mutation Subtypes and Co-Occurring Mutations on Response and Outcome in Advanced NSCLC Patients following First-Line Treatment. Journal of Clinical Medicine, 11(14), 4003.
https://doi.org/10.3390/jcm11144003